Quantcast
Last updated on April 18, 2014 at 12:26 EDT

Latest Tianyin Pharmaceutical Co. Inc. Stories

2011-03-17 11:30:00

CHENGDU, China, March 17, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals announced the relocation of TPI 2010 Annual Shareholder Meeting to the 26th floor, Conference Room E of 100 Wall Street near NYSE at 10:00 am (EDT). Shareholders will be admitted beginning at 9:30 am. The relocation is due...

2011-03-11 09:00:00

CHENGDU, China, March 11, 2011 /PRNewswire-Asia-FirstCall/ --Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals is invited to present at the 23rd ROTH Annual OC Growth Stock Conference from March 13 - 16, 2011 at the Ritz Carlton in Dana Point, California. Dr. James Jiayuan Tong, Chief Financial Officer, Chief Business &...

2011-02-14 07:45:00

CHENGDU, China, Feb. 14, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the second quarter of Fiscal Year 2011. Second quarter fiscal year 2011 ending December 31, 2010 financial highlights Revenue increased 69.6% year over year to $25.3 million from...

2011-02-08 09:00:00

CHENGDU, China, Feb. 8, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a pharmaceutical company that develops, manufactures and markets patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, today announced that the senior management will host a conference call to discuss its fiscal year 2011 second quarter financial results at 8:30 a.m. E.T. on Tuesday, February 15, 2011. Interested parties...

2011-01-26 13:00:00

CHENGDU, China, Jan. 26, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals announced the completion of the construction of its Jiangchuan macrolide facility (JCM) at Xinjin Industrial Development Area, near Chengdu, China. JCM is designed to produce the Phase I annual capacity of 240 ton,...

2011-01-07 17:40:00

CHENGDU, China, Jan. 7, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals today announced that the Company's 2010 Annual Meeting of Stockholders will be held at New York Stock Exchange Conference Room 632 on Monday, March 21, 2011, at 10:00 am (EST). Tianyin's Board of Directors has established...

2010-12-01 07:00:00

CHENGDU, China, Dec. 1, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, has been invited to present at OneMedForum San Francisco 2011 on January 10-13, 2011 at Sir Francis Drake Hotel at 450 Powell Street, San Francisco, CA 94102. Dr. James Jiayuan Tong, TPI's Chief Financial Officer,...

2010-11-16 07:00:00

BEIJING, Nov. 16, 2010 /PRNewswire-Asia-FirstCall/ -- Dr. James Jiayuan Tong, Chief Financial Officer, Chief Business & Development Officer and Director of Tianyin Pharmaceutical (NYSE Amex: TPI) is invited to present at CFO China Summit 2011 which will be held at the St. Regis Hotel at 21 Jianguomenwai Avenue, Beijing 100020, China on January 19, 2011. Dr. Tong will present in two panel discussions: Implementing Effective Working Capital Management Strategies in China at 11:15 am...

2010-11-10 08:08:00

CHENGDU, China, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals announced financial results for the first quarter of Fiscal Year 2011. First quarter fiscal year 2011 ending September 30, 2010 financial highlights 1Q FY2011 revenue increased 63.7% year over year to $22.0 million from...

2010-11-09 23:00:00

CHENGDU, China, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals will attend Brean Murray, Carret & Co. 2010 China Growth Conference on November 17 - 18, 2010 at the Millennium Broadway Hotel (145 West 44th Street) in New York City. Dr. James Jiayuan Tong, Tianyin's Chief...